Advanced eye care The Eye Institute of Utah operates a state-of-the-art facility with a focus on advanced procedures such as all-laser LASIK, ICL surgery, and corneal cross-linking, indicating opportunities to upsell premium vision correction technologies and post-operative care services to existing patients and expand cross-selling with refractive and corneal specialties.

Innovative treatments Recent launches include Epioxa corneal cross-linking and Valeda therapy for dry AMD, signaling openness to adopting innovative, FDA-approved treatments and potential partnerships with equipment/technology vendors, training programs, and supply agreements.

Growth potential Revenue range of 10M–25M and a staff size of 11–50 suggest a mid-sized practice with room for regional expansion, partnerships with payers, concierge services, and tele-ophthalmology initiatives to broaden patient access and drive referrals.

Research leadership Describes the organization as a leader in research and innovation in ophthalmology, presenting opportunities for clinical collaborations, pilot studies, sponsored trials, and academic partnerships to showcase capabilities and attract funding.

Strategic partnerships Diverse tech stack and notable device launches imply potential for partnerships in digital marketing, patient engagement platforms, imaging/software integrations, and performance marketing agencies to amplify patient acquisition and retention.